Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
9,010.00
+60.00 (0.67%)
Jan 19, 2026, 3:30 PM KST
-13.37% (1Y)
| Market Cap | 208.15B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 23.26M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130,613 |
| Average Volume | 129,370 |
| Open | 8,950.00 |
| Previous Close | 8,950.00 |
| Day's Range | 8,930.00 - 9,160.00 |
| 52-Week Range | 6,970.00 - 12,670.00 |
| Beta | 0.92 |
| RSI | 34.30 |
| Earnings Date | Nov 11, 2025 |